Novo Nordisk Reportedly Seeks Lower Prices From Suppliers to Stay Competitive

 Novo Nordisk ( NVO ) is seeking lower prices from suppliers to lower its own expenses to remain competitive with rivals in the weight-loss drug market, news outlets reported Thursday.

Bloomberg cited a statement from the company that it was seeking lower raw materials costs in order to compete commercially.

The Danish news outlet Finans, which first reported the news, said the suppliers were told if they didn't comply it could hut future deals.

https://www.fidelity.com/news/article/company-news/202607020637MIDNIGHTUSEQUITY_A3658685